Treatment of amyotrophic lateral sclerosis with nimesulide
OwnerGiulio Pasinettiinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for delaying the onset or progression of motor impairment associated with amyotrophic lateral sclerosis in a subject by administering to the subject a therapeutically effective amount of nimesulide. It further provides for a means of detecting and monitoring the progression of amyotrophic lateral sclerosis via a protein biomarker for the disease.
Claims19
A method of delaying the onset of motor impairment associated with amyotrophic lateral sclerosis in a human subject comprising administering, to the subject, an effective amount of nimesulide.
A method of treating a human subject diagnosed with amyotrophic lateral sclerosis, comprising administering, to the subject, an amount of nimesulide effective in delaying the onset of impairment of a motor function not measurably impaired prior to the initiation of of the treatment.
An assay method for determining the effect of a test agent on the progression of motor function impairment, comprising:
- (i) administering, to a mouse which serves as a murine model of motor system disease, the test agent;
- and
- (ii) determining the level of expression, in nervous system tissue of the mouse, of a protein having a molecular weight of about 4.5-6.0 kDa and having a negative charge at pH 9, and
- (iii) comparing the level determined in step (ii) with the level of the protein in a control mouse,
- wherein a decrease in the level of the protein in the mouse treated with the test agent relative to the level in the control mouse has a positive correlation with the ability of the test agent to delay motor function impairment.
Dependencies are inferred from the claim text.